DAPA-CKD Resets eGFR Floor for Safe SGLT2 Inhibitor Use DAPA-CKD Resets eGFR Floor for Safe SGLT2 Inhibitor Use

‘ It ' s time to reduce the eGFR level for initiating an SGLT2 inhibitor to as low as 25, ’ suggests an expert.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news